Dec 2019 $5 M No. 6 $2 to $10 million 15
Bioquiddity Inc.: Raise no. 6, Dec 2019 × Investors in this round 15 investors had bought by the notice of Jan 10, 2020: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $19 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Ron W. Pauli · Executive Officer Christopher J. Portman · Director Daniel J. Tasse · Director Llew J. Keltner · Director Mark J. Ehlert · Director Norvall William Jasper, Jr. · Director Richard J. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joshua W. Kriesel, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Jan 10, 2020. Read the notice at the SEC .
debt, options SEC Aug 2017 $6 M No. 5 $2 to $10 million 2
Bioquiddity Inc.: Raise no. 5, Aug 2017 × Investors in this round 2 investors had bought by the notice of Aug 10, 2017: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Ron W. Pauli · Executive Officer Christopher J. Portman · Director Daniel J. Tasse · Director Llew J. Keltner · Director Mark J. Ehlert · Director Norvall William Jasper, Jr. · Director Richard J. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joshua W. Kriesel, Chief executive officer and president. Source: SEC Form D, newest notice filed Aug 10, 2017. Read the notice at the SEC .
options SEC Oct 2016 $15 M No. 4 $10 to $50 million 1
Bioquiddity Inc.: Raise no. 4, Oct 2016 × Investors in this round 1 investor had bought by the notice of Oct 20, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $130,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Ron W. Pauli · Executive Officer Christopher J. Portman · Director Daniel J. Tasse · Director Llew J. Keltner · Director Mark J. Ehlert · Director Norvall William Jasper, Jr. · Director Richard J. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Credo 180, LLC · broker-dealer Trump Securities, LLC (CRD 47107) · New York, New York Sold in NY Remarks in the notice On the amounts: “This amount includes $2,040,000 for the exercise price of the warrants.”Signed by Joshua W. Kriesel, Chief executive officer and president. Source: SEC Form D, newest notice filed Oct 20, 2016. Read the notice at the SEC .
debt, options SEC Nov 2015 $36 M No. 3 $10 to $50 million 52
Bioquiddity Inc.: Raise no. 3, Nov 2015 × Investors in this round 52 investors had bought by the notice of Nov 5, 2018: 52 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $36 M of $45 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $102,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Ron W. Pauli · Executive Officer Christopher J. Portman · Director Daniel J. Tasse · Director Llew J. Keltner · Director Mark J. Ehlert · Director Norvall William Jasper, Jr. · Director Richard J. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Canaccord Genuity Inc. (CRD 1020) · New York, New York Sold in MA Signed by Joshua W. Kriesel, President. Source: SEC Form D and 2 amendments, newest notice filed Nov 5, 2018. Read the notice at the SEC .
equity SEC Oct 2014 $14 M No. 2 $10 to $50 million 2
Bioquiddity Inc.: Raise no. 2, Oct 2014 × Investors in this round 2 investors had bought by the notice of Nov 10, 2014: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $250,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Ron W. Pauli · Executive Officer Christopher J. Portman · Director Llew J. Keltner · Director Mark J. Ehlert · Director Norvall William Jasper, Jr. · Director Richard J. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Armentum Partners LLC · broker-dealer Trump Securities, LLC (CRD 47107) · San Francisco, California Sold in CA Remarks in the notice On fees: “In addition, a warrant exercisable for $112,000 of common stock was issued as part of the sales commission, which amount has been included in Item 13 above.”On the amounts: “The total offering amount includes $1,237,000.00 for the exercise price for warrants.”Signed by Joshua W. Kriesel, President. Source: SEC Form D, newest notice filed Nov 10, 2014. Read the notice at the SEC .
debt, options SEC Apr 2013 $8 M No. 1 $2 to $10 million 51
Bioquiddity Inc.: Raise no. 1, Apr 2013 × Investors in this round 51 investors had bought by the notice of Apr 19, 2013: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $15 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Joshua W. Kriesel · Executive Officer, Director Christopher A. Portman · Director Llew J. Keltner · Director Mark J. Ehlert · Director Marshall S. Kriesel · Director Richard A. Nesbit · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joshua W. Kriesel, President. Source: SEC Form D, newest notice filed Apr 19, 2013. Read the notice at the SEC .
equity SEC